CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, M.
Right arrow Articles by Zheng, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, M.
Right arrow Articles by Zheng, W.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 1301-1302, December 2001
© 2001 American Association for Cancer Research


Null Results in Brief

No Apparent Association of GSTP1 A313G Polymorphism with Breast Cancer Risk among Postmenopausal Iowa Women1

Mingfang Zhao, Ryan Lewis, Deborah R. Gustafson, Wan-Qing Wen, James R. Cerhan and Wei Zheng2

Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-8300 [M. Z., W-Q. W., W. Z.]; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina [R. L.]; Department of Nutrition and Food Sciences, Utah State University, Logan, Utah 84322-8700 [D. R. G.]; and Department of Health Science Research, Mayo Clinic Cancer, Rochester, Minnesota 55905 [J. R. C.]


    Introduction
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
GSTP13 catalyzes the conjugating reactions of PAHs and their electrophilic compounds to facilitate their excretion (1) . Burned foods and cigarette smoke contain mammary carcinogens such as PAHs (2) . Mice treated with PAHs had an elevated risk of skin tumors, particularly among those without the GSTP1 gene (3) . The expression of the GSTP1 gene has been observed in many human tissues including breast epithelium (4) .

A polymorphic adenine to guanine transition at nucleotide 313 (A313G) in exon 5 results in an isoleucine to valine substitution in codon 105 (I105V) (5) . This codon is located in the substrate-binding site of GSTP1, and the corresponding allozymes exhibited differential catalytic activities toward diverse substrates (5) . Epidemiological studies associating GSTP1 polymorphism with breast cancer risk are few and inconsistent (6 , 7) . To evaluate the role of this polymorphism and its joint effect with PAH exposure in the risk of breast cancer, we analyzed data from a case-control study conducted among postmenopausal women in Iowa.


    Materials and Methods
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A nested case-control study of breast cancer was conducted within the Iowa Women’s Health Study, a prospective cohort study of 41,836 postmenopausal Caucasian women who completed a self-administered baseline questionnaire in January 1986. A supplementary survey on meat-eating habit was completed during 1995 to 1996 in 273 breast cancer cases diagnosed during 1992 to 1994 and 657 women randomly selected from the cohort members without any cancer diagnosis in 1992. Of them, blood samples were obtained from 488 women (156 cases and 332 controls). Genomic DNA from peripheral white blood cells was used to determine the genotypes of the GSTP1 gene using the PCR-RFLP method. The primers for the PCR reactions were GSTP1 forward 5'-ccagtgactgtgtgttgatc-3' and reverse 5'-caaccctggtgcagatgctc-3'. The PCR reactions were carried out in a 50-µl mixture containing sample DNA, 20 mM Tris-HCl (pH 8.4), 5.0 mM KCl, 1.5 mM MgCl2, 0.2 mM deoxynucleotide triphosphate 1 unit of Taq polymerase, and 0.4 µM of each oligonucleotide primer. Amplification, which resulted in a 189-bp fragment, was achieved by 35 cycles of 30 s at 94°C, 30 s at 62°C, and 30 s at 72°C. At the end, the reactions were extended for 7 min at 72°C. Each PCR product (5 µl) was subjected to BsmAI digestion and analyzed by gel electrophoresis (3% 2:1 Nosier/SeaKem agarose). The presence of the polymorphic BsmAI restriction site yields 148- and 41-bp fragments, indicating the presence of the G allele.

ORs and their 95% CIs were derived from unconditional logistic regression models and were adjusted for potential confounding variables. Trend tests for dose-response across levels of the exposure variables were performed by treating ordinal-score variables as continuous variables in logistic regression models. Reported Ps are based on two-sided probability tests, with a significance level of P < 0.05.


    Results
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The frequency of the variant allele was 29%, consistent with that reported from a previous study (7) . There is no statistical significant association between A313G polymorphism and breast cancer risk (Table 1)Citation . This polymorphism was not found to modify the association of well-done meat intake or cigarette smoking with breast cancer risk.


View this table:
[in this window]
[in a new window]
 
Table 1 Evaluation of GSTP1 polymorphism and its modifying effect on the risk of breast cancer among postmenopausal Iowa women

 

    Discussion
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It was reported that the catalytic efficiency of the valine-containing allozyme was elevated in conjugating several carcinogenic intermediates of PAHs but reduced for other substrates, such as 1-chloro-2,4-dinitro-benzene (5) . A recent study reported no clear relationship between the genotypes of GSTP1 A313A polymorphism and the activities of corresponding allozymes (8) . Furthermore, the 5' promoter region of GSTP1 contains GC-rich regions that are prone to be hypermethylated and lose gene expression (9) . Therefore, GSTP1 5'-end hypermethylation may overwrite or mask the functional variations of GSTP1 I105V allozymes. The functional significance of the A313G polymorphism of the GSTP1 gene remains unclear.

One potential concern of the study may be its low response rate. However, it is unlikely that selection bias can explain the null association, because the GSTP1 genotype was unlikely to be associated with study participation.

Our study has an 80% statistical power to detect an OR of 1.74 for the GSTP1 AG and GG genotypes compared with the AA genotype at the significance level of 0.05. The statistical power to examine the interaction was further limited. Nevertheless, this study showed that there was no apparent association of GSTP1 polymorphism with breast cancer risk, and the modifying effect of GSTP1 polymorphism, if any, on the association of well-done meat intake and smoking with breast cancer risk was unlikely to be substantial.


    Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by USPHS Grant RO1CA39742 from the NIH and by Supplementary Grant OWH-284 from the National Action Plan on Breast Cancer, Office on Women’s Health, Public Health Service. Back

2 To whom requests for reprints should be addressed, at Vanderbilt University Medical Center, Center for Health Services Research, Medical Center East, 6th Floor, Nashville, TN 37232-8300. Phone: (615) 936-0682; Fax: (615) 936-1269; E-mail: Wei.Zheng{at}mcmail.vanderbilt.edu Back

3 The abbreviations used are: GSTP1, glutathione S-transferase {pi}; OR, odds ratio; CI, confidence interval; PAH, polycyclic aromatic hydrocarbon. Back

Received 3/12/01; revised 7/27/01; accepted 10/ 1/01.


    References
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Harries L. W., Stubbins M. J., Forman D., Howard G. C. W., Wolf C. R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular, and prostate cancer. Carcinogenesis (Lond.), 18: 641-644, 1997.[Abstract/Free Full Text]
  2. Rundle A., Tang D., Hibshoosh H., Estabrook A., Schnabel F., Cao W., Grumet S., Perera F. P. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis (Lond.), 21: 1281-1289, 2000.[Abstract/Free Full Text]
  3. Henderson C. J., Smith A. G., Ure J., Brown K., Bacon E. J., Wolf C. R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. USA, 95: 5275-5280, 1998.[Abstract/Free Full Text]
  4. Forrester L. M., Hayes J. D., Millis R., Barnes D., Harris A. L., Schlager J. J., Powis G., Wolf C. R. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis (Lond.), 11: 2163-2170, 1990.[Abstract/Free Full Text]
  5. Hu X., Xia H., Srivastava S. K., Herzog C., Awasthi Y. C., Ji X., Zimniak P., Singh S. V. Activity of four allelic forms of glutathione S-transferase hGSTP1–1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun., 238: 397-402, 1997.[Medline]
  6. Dunning A. M., Healey C. S., Pharoah P. D. P., Teare M. D., Ponder B. A. J., Easton D. F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 8: 843-854, 1999.[Abstract/Free Full Text]
  7. Mitrunen K., Jourenkova N., Kataja V., Eskelinen M., Kosma V-M., Benhamou S., Vainio H., Uusitupa M., Hirvonen A. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol. Biomark. Prev., 10: 229-236, 2001.[Abstract/Free Full Text]
  8. Board P., Harris M., Flanagan J., Langton L., Coggan M. Genetic heterogeneity of the structure and function of GSTT2 and GSTP1. Chemico-Biol. Interact., 111–112: 83-89, 1998.
  9. Esteller M., Corn P. G., Urena J. M., Gabrielson E., Baylin S. B., Herman J. G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res., 58: 4515-4518, 1998.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
S.-A. Lee, J. H Fowke, W. Lu, C. Ye, Y. Zheng, Q. Cai, K. Gu, Y.-T. Gao, X.-o. Shu, and W. Zheng
Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 753 - 760.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.E. Steck, M.M. Gaudet, J.A. Britton, S.L. Teitelbaum, M.B. Terry, A.I. Neugut, R.M. Santella, and M.D. Gammon
Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk
Carcinogenesis, September 1, 2007; 28(9): 1954 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. D. Vogl, E. Taioli, C. Maugard, W. Zheng, L. F. Ribeiro Pinto, C. Ambrosone, F. F. Parl, V. Nedelcheva-Kristensen, T. R. Rebbeck, P. Brennan, et al.
Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1473 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu
An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology
Cancer Res., March 15, 2004; 64(6): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. M. Egan, Q. Cai, X.-O. Shu, F. Jin, T.-L. Zhu, Q. Dai, Y.-T. Gao, and W. Zheng
Genetic Polymorphisms in GSTM1, GSTP1, and GSTT1 and the Risk for Breast Cancer: Results from the Shanghai Breast Cancer Study and Meta-Analysis
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 197 - 204.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. H. Fowke, X.-O. Shu, Q. Dai, A. Shintani, C. C. Conaway, F.-L. Chung, Q. Cai, Y.-T. Gao, and W. Zheng
Urinary Isothiocyanate Excretion, Brassica Consumption, and Gene Polymorphisms among Women Living in Shanghai, China
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1536 - 1539.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, M.
Right arrow Articles by Zheng, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, M.
Right arrow Articles by Zheng, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation